EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study

Floran Sahiti iD, Vladimir Cejka iD, Lena Schmidbauer iD, Judith Albert, Fabian Kerwagen iD, Stefan Frantz iD, Götz Gelbrich, Peter U Heuschmann iD, Stefan Störk iD, Caroline Morbach iD, of the STAAB consortium *

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.035549 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Floran Sahiti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center University Hospital and University of Wurzburg Germany. Hauptthemen laut MEDLINE: Pericardial Effusion, Incidental Findings, Echocardiography, Peptide Fragments. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidental finding of a pericardial effusion (PE) poses a challenge in clinical care. PE is associated with malignant conditions or severe cardiac disease but may also be observed in healthy individuals. This study explored the prevalence, determinants, course, and prognostic relevance of PE in a population‐based cohort. Methods and Results The STAAB (Characteristics and Course of Heart Failure Stages A/B and Determinants of Progression) cohort study recruited a representative sample of the population of Würzburg, aged 30 to 79 years. Participants underwent quality‐controlled transthoracic echocardiography including the dedicated evaluation of the pericardial space. Of 4965 individuals included at baseline (mean age, 55±12 years; 52% women), 134 (2.7%) exhibited an incidentally diagnosed PE (median diameter, 2.7 mm; quartiles, 2.0–4.1 mm). In multivariable logistic regression, lower body mass index and higher NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) levels were associated with PE at baseline, whereas inflammation, malignancy, and rheumatoid disease were not. Among the 3901 participants attending the follow‐up examination after a median time of 34 (30–41) months, PE was found in 60 individuals (1.5%; n=18 new PE, n=42 persistent PE). Within the follow‐up period, 37 participants died and 93 participants reported a newly diagnosed malignancy. The presence of PE did not predict all‐cause death or the development of new malignancy.

Conclusions

Incidental PE was detected in about 3% of individuals, with the vast majority measuring

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pericardial EffusionIncidental FindingsEchocardiographyPeptide FragmentsHumansFemaleMiddle AgedMaleAgedAdultPrognosisPrevalenceNatriuretic Peptide, BrainRisk FactorsBiomarkersHeart FailurePredictive Value of TestsDisease ProgressionTime Factors

Stichwörter der Autor:innen

incidental findingpericardial effusionpopulation‐based cohortprognostic relevance

Substanzen

Peptide FragmentsNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)Biomarkers

Autor:innen und Institutionen

  • Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center University Hospital and University of Wurzburg Germany.
  • Department of Medicine I, Division of Cardiology University Hospital of Wurzburg Germany.
  • Institute of Clinical Epidemiology and Biometry University of Wurzburg Germany.
  • Clinical Trial Center University Hospital and University of Wurzburg Germany.
  • Institute of Medical Data Science University Hospital Wurzburg Germany.

ORCID-Profile: Floran Sahiti, Vladimir Cejka, Lena Schmidbauer, Fabian Kerwagen, Stefan Frantz, Peter U Heuschmann, Stefan Störk, Caroline Morbach

Zitieren

APA

Sahiti, F., Cejka, V., Schmidbauer, L., Albert, J., Kerwagen, F., Frantz, S., Gelbrich, G., Heuschmann, P. U., Störk, S., Morbach, C., & of the STAAB consortium * (2024). Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.035549

Vancouver

Sahiti F, Cejka V, Schmidbauer L, Albert J, Kerwagen F, Frantz S, et al. Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.035549

BibTeX
@article{Sahiti2024,
  author = {Sahiti, Floran and Cejka, Vladimir and Schmidbauer, Lena and Albert, Judith and Kerwagen, Fabian and Frantz, Stefan and Gelbrich, Götz and Heuschmann, Peter U and Störk, Stefan and Morbach, Caroline and of the STAAB consortium *, of the STAAB consortium *},
  title = {Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.035549}
}
Kostenlos starten →